Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?

P. VANDERKAM ; S. GAGEY ; P. INGRAND ; M. C. PERAULT-POCHAT ; Y. BRABANT ; C. BLANCHARD ; B. TUDREJ ; N. MESSAADI ; P. BINDER | 2018
Dans Drug and Alcohol Dependence (Vol.188, July 2018) Article : Périodique

Background: In France, buprenorphine is at once the most widely prescribed and the most commonly misused opioid maintenance treatment (OMT). Unlike other medicines, it is seldom prescribed as a generic drug. Several studies have underlined the i[...]

Plus d'info

Ajouter à la sélection

Preference for brand-name buprenorphine is related to severity of addiction among outpatients in opioid maintenance treatment

P. BINDER ; N. MESSAADI ; M. C. PERAULT-POCHAT ; S. GAGEY ; Y. BRABANT ; P. INGRAND | 2016
Dans Journal of Addictive Diseases (Vol.35, n°2, 2016) Article : Périodique

As a form of opioid maintenance treatment, high-dose buprenorphine is increasingly being used in the United States. On the French market since 1996, it is the most commonly prescribed and frequently employed opioid maintenance treatment. For unk[...]

Plus d'info

Ajouter à la sélection